FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ole Mjøs

Research Profile

Living Beings

Chemicals & Drugs

Disorders

Anatomy

Procedures

Myocardial Ischemic Preconditioning

Physiology

Phenomena

Phosphorylation

Co-author Network

Publications

TOP 3
Anne K Jonassen; Ole D Mjøs; Anita Wergeland; Erik Helgeland; Bhawanjit K Brar
Activation of corticotropin releasing factor receptor type 2 in the heart by corticotropin releasing factor offers cytoprotection against ischemic injury via PKA and PKC dependent signaling.
B N Fuglesteg; C Tiron; Anne K Jonassen; Ole D Mjøs; Kirsti Ytrehus
Pretreatment with insulin before ischaemia reduces infarct size in Langendorff-perfused rat hearts.
Britt N Fuglesteg; Naushaad Suleman; Crina Tiron; Tambuzai Kanhema; Lydia Lacerda; Thomas Andreasen; Michael N Sack; Anne K Jonassen; Ole D Mjøs; Lionel Henry Opie; Sandrine Lecour
Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusion.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ole Mjøs (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Anne K Jonassen; Ole D Mjøs; Anita Wergeland; Erik Helgeland; Bhawanjit K Brar
Activation of corticotropin releasing factor receptor type 2 in the heart by corticotropin releasing factor offers cytoprotection against ischemic injury via PKA and PKC dependent signaling.
Regulatory peptides 2012;174(1-3):90-7.
2009: B N Fuglesteg; C Tiron; Anne K Jonassen; Ole D Mjøs; Kirsti Ytrehus
Pretreatment with insulin before ischaemia reduces infarct size in Langendorff-perfused rat hearts.
Acta physiologica (Oxford, England) 2009;195(2):273-82.
2008: Britt N Fuglesteg; Naushaad Suleman; Crina Tiron; Tambuzai Kanhema; Lydia Lacerda; Thomas Andreasen; Michael N Sack; Anne K Jonassen; Ole D Mjøs; Lionel Henry Opie; Sandrine Lecour
Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusion.
Basic research in cardiology 2008;103(5):444-53.
2007: Ole D Mjøs
Biotechnology, health, and peace. Foreword.
Biotechnology annual review 2007;13():v-viii.
2006: Joel Starkopf; Stig Hegna; Odd Erik Johansen; Jens Munch-Ellingsen; Ole D Mjøs; Kirsti Ytrehus
In vivo chronic carvedilol treatment in rats attenuates ex vivo regional infarction of the heart.
Scandinavian cardiovascular journal : SCJ 2006;40(4):240-7.
2004: Thale Henden; Ellen Aasum; Lars P Folkow; Ole D Mjøs; David Austin Lathrop; Terje S Larsen
Endogenous glycogen prevents Ca2+ overload and hypercontracture in harp seal myocardial cells during simulated ischemia.
Journal of molecular and cellular cardiology 2004;37(1):43-50.
2004: Anne K Jonassen; Ole D Mjøs; Michael N Sack
p70s6 kinase is a functional target of insulin activated Akt cell-survival signaling.
Biochemical and biophysical research communications 2004;315(1):160-5.
2004: Bhawanjit K Brar; Anne K Jonassen; Elena M Egorina; Alon Chen; Alejandra Negro; Marilyn H Perrin; Ole D Mjøs; David S Latchman; Kuo-Fen Lee; Wylie Vale
Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart.
Endocrinology 2004;145(1):24-35; discussion 21-3.
2001: Anne K Jonassen; Michael N Sack; Ole D Mjøs; Derek M Yellon
Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling.
Circulation research 2001;89(12):1191-8.
2000: Anne K Jonassen; Ellen Aasum; Rudolph A Riemersma; Ole D Mjøs; Terje S Larsen
Glucose-insulin-potassium reduces infarct size when administered during reperfusion.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2000;14(6):615-23.
2000: Anne K Jonassen; Bhawanjit K Brar; Ole D Mjøs; Michael N Sack; David S Latchman; Derek M Yellon
Insulin administered at reoxygenation exerts a cardioprotective effect in myocytes by a possible anti-apoptotic mechanism.
Journal of molecular and cellular cardiology 2000;32(5):757-64.
2000: Michael N Sack; L S Harrington; Anne K Jonassen; Ole D Mjøs; Derek M Yellon
Coordinate regulation of metabolic enzyme encoding genes during cardiac development and following carvedilol therapy in spontaneously hypertensive rats.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2000;14(1):31-9.